Journal
JOURNAL OF MEDICINAL CHEMISTRY
Volume 49, Issue 12, Pages 3659-3666Publisher
AMER CHEMICAL SOC
DOI: 10.1021/jm051202e
Keywords
-
Categories
Ask authors/readers for more resources
1-Benzyl-5-aryltetrazoles were discovered to be novel antagonists for the P2X(7) receptor. Structure-activity relationship (SAR) studies were conducted around both the benzyl and phenyl moieties. In addition, the importance of the regiochemical substitution on the tetrazole was examined. Compounds were evaluated for activity to inhibit calcium flux in both human and rat recombinant P2X7 cell lines using fluorometric imaging plate reader technology. Analogues were also assayed for their ability to inhibit IL-1 beta release and to inhibit P2X(7)-mediated pore formation in human THP-1 cells. Compound 15d was advanced to efficacy studies in a model of neuropathic pain where significant reversal of mechanical allodynia was observed at doses that did not affect motor coordination.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available